The DOI matches its Crossref record; 173 of the 173 references it cites were found in a registry or an index.
Quinolones: Mechanism, Lethality and Their Contributions to Antibiotic Resistance
Open accessAbstract
Fluoroquinolones (FQs) are arguably among the most successful antibiotics of recent times. They have enjoyed over 30 years of clinical usage and become essential tools in the armoury of clinical treatments. FQs target the bacterial enzymes DNA gyrase and DNA topoisomerase IV, where they stabilise a covalent enzyme-DNA complex in which the DNA is cleaved in both strands. This leads to cell death and turns out to be a very effective way of killing bacteria. However, resistance to FQs is increasingly problematic, and alternative compounds are urgently needed. Here, we review the mechanisms of action of FQs and discuss the potential pathways leading to cell death. We also discuss quinolone resistance and how quinolone treatment can lead to resistance to non-quinolone antibiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Origins and evolution of antibiotic resistance
Davies, J., & Davies, D. (2010) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00016-10 · Cited by 5,784
Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.
Hsiang, Y. H., Hertzberg, R., Hecht, S., & Liu, L. F. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38654-4 · Cited by 2,362
Food Animals and Antimicrobials: Impacts on Human Health
Marshall, B. M., & Levy, S. B. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00002-11 · Cited by 2,241
Imlay, J. A. (2003) · Annual Review of Microbiology · doi:10.1146/annurev.micro.57.030502.090938 · Cited by 2,203
Antibiotics and Bacterial Resistance in the 21st Century
Fair, R. J., & Tor, Y. (2014) · Perspectives in Medicinal Chemistry · doi:10.4137/pmc.s14459 · Cited by 1,955
Wang, J. C. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.003223 · Cited by 1,832
Imlay, J. A. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3032 · Cited by 1,684
Molecular Mechanisms of Antibacterial Multidrug Resistance
Alekshun, M. N., & Levy, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.03.004 · Cited by 1,647
DNA gyrase, topoisomerase IV, and the 4-quinolones.
Drlica, K., & Zhao, X. (1997) · Microbiology and molecular biology reviews : MMBR · doi:10.1128/.61.3.377-392.1997 · Cited by 1,494
Mechanism of Quinolone Action and Resistance
Aldred, K. J., Kerns, R. J., & Osheroff, N. (2014) · Biochemistry · doi:10.1021/bi5000564 · Cited by 1,282
Persistent bacterial infections and persister cells
Fisher, R. A., Gollan, B., & Helaine, S. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.42 · Cited by 1,243
DNA gyrase: an enzyme that introduces superhelical turns into DNA.
Gellert, M., Mizuuchi, K., O'Dea, M. H., & Nash, H. A. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.11.3872 · Cited by 1,204
Phillips, I. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg483 · Cited by 1,100
Quinolone resistance from a transferable plasmid
Martínez-Martínez, L., Pascual, A., & Jacoby, G. A. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07322-4 · Cited by 1,100
Origins and evolution of antibiotic resistance.
DAVIES, J. E. (1996) · PubMed · Cited by 1,033
Hsiang, Y. H., Lihou, M. G., & Liu, L. F. (1989) · PubMed · Cited by 1,028
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase
Robicsek, A., Strahilevitz, J., Jacoby, G. A., Macielag, M., Abbanat, D., Hye Park, C., Bush, K., & Hooper, D. C. (2006) · Nature Medicine · doi:10.1038/nm1347 · Cited by 1,013
Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success
Redgrave, L. S., Sutton, S. B., Webber, M. A., & Piddock, L. J. V. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2014.04.007 · Cited by 1,008
Sublethal Antibiotic Treatment Leads to Multidrug Resistance via Radical-Induced Mutagenesis
Kohanski, M. A., DePristo, M. A., & Collins, J. J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.01.003 · Cited by 985
Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat
Strahilevitz, J., Jacoby, G. A., Hooper, D. C., & Robicsek, A. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00016-09 · Cited by 928
Lomovskaya, O., Warren, M. S., Lee, A., Galazzo, J., Fronko, R., Lee, M., Blais, J., Cho, D., Chamberland, S., Renau, T., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.105-116.2001 · Cited by 903
Adaptive and Mutational Resistance: Role of Porins and Efflux Pumps in Drug Resistance
Fernández, L., & Hancock, R. E. W. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00043-12 · Cited by 892
Type IIA topoisomerase inhibition by a new class of antibacterial agents
Bax, B. D., Chan, P. F., Eggleston, D. S., Fosberry, A., Gentry, D. R., Gorrec, F., Giordano, I., Hann, M. M., Hennessy, A., Hibbs, M., et al. (2010) · Nature · doi:10.1038/nature09197 · Cited by 860
Nalidixic acid resistance: A second genetic character involved in DNA gyrase activity
Gellert, M., Mizuuchi, K., O'Dea, M. H., Itoh, T., & Tomizawa, J.-I. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.11.4772 · Cited by 833
Sugino, A., Peebles, C. L., Kreuzer, K. N., & Cozzarelli, N. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.11.4767 · Cited by 784
Bacterial Topoisomerase Inhibitors: Quinolone and Pyridone Antibacterial Agents
Mitscher, L. A. (2005) · Chemical Reviews · doi:10.1021/cr030101q · Cited by 781
Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli
Yoshida, H., Bogaki, M., Nakamura, M., Yamanaka, L. M., & Nakamura, S. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.8.1647 · Cited by 777
1,8-Naphthyridine Derivatives. A New Class of Chemotherapeutic Agents
Lesher, G. Y., Froelich, E. J., Gruett, M. D., Bailey, J. H., & Brundage, R. P. (1962) · Journal of Medicinal and Pharmaceutical Chemistry · doi:10.1021/jm01240a021 · Cited by 766
Mechanisms of drug resistance: quinolone resistance
Hooper, D. C., & Jacoby, G. A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12830 · Cited by 716
Structure-activity and structure-side-effect relationships for the quinolone antibacterials
Domagala, J. M. (1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/33.4.685 · Cited by 681
Fluoroquinolone antimicrobial agents
Wolfson, J. S., & Hooper, D. C. (1989) · Clinical Microbiology Reviews · doi:10.1128/cmr.2.4.378 · Cited by 649
The fluoroquinolone antibacterials: past, present and future perspectives
Appelbaum, P. C., & Hunter, P. A. (2000) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(00)00192-8 · Cited by 629
The Role of Reactive Oxygen Species in Antibiotic-Mediated Killing of Bacteria
Van Acker, H., & Coenye, T. (2017) · Trends in Microbiology · doi:10.1016/j.tim.2016.12.008 · Cited by 619
Exploiting bacterial DNA gyrase as a drug target: current state and perspectives
Collin, F., Karkare, S., & Maxwell, A. (2011) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-011-3557-z · Cited by 606
Self-citationCell Death from Antibiotics Without the Involvement of Reactive Oxygen Species
Liu, Y., & Imlay, J. A. (2013) · Science · doi:10.1126/science.1232751 · Cited by 593
Inhibition of Mutation and Combating the Evolution of Antibiotic Resistance
Cirz, R. T., Chin, J. K., Andes, D. R., de Crécy-Lagard, V., Craig, W. A., & Romesberg, F. E. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030176 · Cited by 576
Quinolone-Mediated Bacterial Death
Drlica, K., Malik, M., Kerns, R. J., & Zhao, X. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01617-06 · Cited by 570
Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli
Yoshida, H., Bogaki, M., Nakamura, M., & Nakamura, S. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.6.1271 · Cited by 570
Topoisomerase Inhibitors: Fluoroquinolone Mechanisms of Action and Resistance
Hooper, D. C., & Jacoby, G. A. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025320 · Cited by 553
Killing by Bactericidal Antibiotics Does Not Depend on Reactive Oxygen Species
Keren, I., Wu, Y., Inocencio, J., Mulcahy, L. R., & Lewis, K. (2013) · Science · doi:10.1126/science.1232688 · Cited by 550
Ahuja, S. D., Ashkin, D., Avendano, M., Banerjee, R., Bauer, M., Bayona, J. N., Becerra, M. C., Benedetti, A., Burgos, M., Centis, R., et al. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001300 · Cited by 535
SOS Response Induces Persistence to Fluoroquinolones in Escherichia coli
Dörr, T., Lewis, K., & Vulić, M. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000760 · Cited by 534
The quinolones: decades of development and use
Emmerson, A. M. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg208 · Cited by 531
Bactericidal Antibiotics Induce Toxic Metabolic Perturbations that Lead to Cellular Damage
Belenky, P., Ye, J. D., Porter, C. B. M., Cohen, N. R., Lobritz, M. A., Ferrante, T., Jain, S., Korry, B. J., Schwarz, E. G., Walker, G. C., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.059 · Cited by 513
Post-stress bacterial cell death mediated by reactive oxygen species
Hong, Y., Zeng, J., Wang, X., Drlica, K., & Zhao, X. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901730116 · Cited by 513
Oxidation of the Guanine Nucleotide Pool Underlies Cell Death by Bactericidal Antibiotics
Foti, J. J., Devadoss, B., Winkler, J. A., Collins, J. J., & Walker, G. C. (2012) · Science · doi:10.1126/science.1219192 · Cited by 497
Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon
Alekshun, M. N., & Levy, S. B. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2067 · Cited by 470
Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coli
Dwyer, D. J., Kohanski, M. A., Hayete, B., & Collins, J. J. (2007) · Molecular Systems Biology · doi:10.1038/msb4100135 · Cited by 469
Crystal structure of the breakage–reunion domain of DNA gyrase
Cabral, J. H. M., Jackson, A. P., Smith, C. V., Shikotra, N., Maxwell, A., & Liddington, R. C. (1997) · Nature · doi:10.1038/42294 · Cited by 456
Self-citationQuinolones: a comprehensive review.
Oliphant, C. M., & Green, G. M. (2002) · PubMed · Cited by 454
The Quinolones: Past, Present, and Future
Andriole, V. T. (2005) · Clinical Infectious Diseases · doi:10.1086/428051 · Cited by 428
Structure, Molecular Mechanisms, and Evolutionary Relationships in DNA Topoisomerases
Corbett, K. D., & Berger, J. M. (2004) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.33.110502.140357 · Cited by 426
Multidrug Efflux Pumps in Staphylococcus aureus: an Update
Costa, S. S., Viveiros, M., Amaral, L., & Couto, I. (2013) · The Open Microbiology Journal · doi:10.2174/1874285801307010059 · Cited by 409
A human 5′-tyrosyl DNA phosphodiesterase that repairs topoisomerase-mediated DNA damage
Ledesma, F. C., El Khamisy, S. F., Zuma, M. C., Osborn, K., & Caldecott, K. W. (2009) · Nature · doi:10.1038/nature08444 · Cited by 408
Van Bambeke, F., Balzi, E., & Tulkens, P. M. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00291-4 · Cited by 404
Yeast Gene for a Tyr-DNA Phosphodiesterase that Repairs Topoisomerase I Complexes
Pouliot, J. J., Yao, K. C., Robertson, C. A., & Nash, H. A. (1999) · Science · doi:10.1126/science.286.5439.552 · Cited by 382
Topoisomerase IV is a target of quinolones in Escherichia coli.
Khodursky, A. B., Zechiedrich, E. L., & Cozzarelli, N. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11801 · Cited by 378
Ferrero, L., Cameron, B., Manse, B., Lagneaux, D., Crouzet, J., Famechon, A., & Blanche, F. (1994) · Molecular Microbiology · doi:10.1111/j.1365-2958.1994.tb00458.x · Cited by 378
Quinolones: Action and Resistance Updated
Drlica, K., Hiasa, H., Kerns, R., Malik, M., Mustaev, A., & Zhao, X. (2009) · Current Topics in Medicinal Chemistry · doi:10.2174/156802609789630947 · Cited by 376
Strumberg, D., Pilon, A. A., Smith, M., Hickey, R., Malkas, L., & Pommier, Y. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.3977-3987.2000 · Cited by 367
Everett, M. J., Jin, Y. F., Ricci, V, & Piddock, L. J. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.10.2380 · Cited by 365
Bates, A. D., & Maxwell, A. (2005) · doi:10.1093/oso/9780198567097.001.0001 · Cited by 355
Self-citationGlobal Fluoroquinolone Resistance Epidemiology and Implictions for Clinical Use
Dalhoff, A. (2012) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2012/976273 · Cited by 354
Van Bambeke, F., Michot, J.-M., Van Eldere, J., & Tulkens, P. M. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01131.x · Cited by 342
Tyrosyl-DNA-phosphodiesterases (TDP1 and TDP2)
Pommier, Y., Huang, S.-Y. N., Gao, R., Das, B. B., Murai, J., & Marchand, C. (2014) · DNA Repair · doi:10.1016/j.dnarep.2014.03.020 · Cited by 336
Mechanisms of quinolone action and resistance: where do we stand?
Correia, S., Poeta, P., Hébraud, M., Capelo, J. L., & Igrejas, G. (2017) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000475 · Cited by 332
Roca, J., & Wang, J. C. (1992) · Cell · doi:10.1016/0092-8674(92)90558-t · Cited by 317
Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance
Wohlkonig, A., Chan, P. F., Fosberry, A. P., Homes, P., Huang, J., Kranz, M., Leydon, V. R., Miles, T. J., Pearson, N. D., Perera, R. L., et al. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1892 · Cited by 310
Structural insight into the quinolone–DNA cleavage complex of type IIA topoisomerases
Laponogov, I., Sohi, M. K., Veselkov, D. A., Pan, X.-S., Sawhney, R., Thompson, A. W., McAuley, K. E., Fisher, L. M., & Sanderson, M. R. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1604 · Cited by 304
Quinolone generations: natural history or natural selection?
Ball, P. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/oxfordjournals.jac.a020889 · Cited by 302
A Fluoroquinolone Resistance Protein from Mycobacterium tuberculosis That Mimics DNA
Hegde, S. S., Vetting, M. W., Roderick, S. L., Mitchenall, L. A., Maxwell, A., Takiff, H. E., & Blanchard, J. S. (2005) · Science · doi:10.1126/science.1110699 · Cited by 291
Self-citationUnraveling the Physiological Complexities of Antibiotic Lethality
Dwyer, D. J., Collins, J. J., & Walker, G. C. (2015) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124712 · Cited by 280
Topological challenges to DNA replication: Conformations at the fork
Postow, L., Crisona, N. J., Peter, B. J., Hardy, C. D., & Cozzarelli, N. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111006998 · Cited by 279
Cirz, R. T., O'Neill, B. M., Hammond, J. A., Head, S. R., & Romesberg, F. E. (2006) · Journal of Bacteriology · doi:10.1128/jb.00807-06 · Cited by 276
Complete and SOS-Mediated Response of Staphylococcus aureus to the Antibiotic Ciprofloxacin
Cirz, R. T., Jones, M. B., Gingles, N. A., Minogue, T. D., Jarrahi, B., Peterson, S. N., & Romesberg, F. E. (2007) · Journal of Bacteriology · doi:10.1128/jb.01464-06 · Cited by 273
Diagnosing oxidative stress in bacteria: not as easy as you might think
Imlay, J. A. (2015) · Current Opinion in Microbiology · doi:10.1016/j.mib.2015.01.004 · Cited by 264
Origins of the Quinolone Class of Antibacterials: An Expanded “Discovery Story”: Miniperspective
Bisacchi, G. S. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501881c · Cited by 252
Strategies for bypassing the membrane barrier in multidrug resistant Gram‐negative bacteria
Bolla, J.-M., Alibert-Franco, S., Handzlik, J., Chevalier, J., Mahamoud, A., Boyer, G., Kieć-Kononowicz, K., & Pagès, J.-M. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.04.054 · Cited by 250
Bush, N. G., Evans-Roberts, K., & Maxwell, A. (2015) · EcoSal Plus · doi:10.1128/ecosalplus.esp-0010-2014 · Cited by 238
Self-citationKreuzer, K. N. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a012674 · Cited by 237
Base excision repair of oxidative DNA damage from mechanism to disease
Freudenthal, B. D. (2017) · Frontiers in Bioscience · doi:10.2741/4555 · Cited by 230
Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli
Hooper, D. C., Wolfson, J. S., Souza, K. S., Tung, C., McHugh, G. L., & Swartz, M. N. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.29.4.639 · Cited by 211
Prevalence of Plasmid-Mediated Quinolone Resistance
Jacoby, G. A., Chow, N., & Waites, K. B. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.2.559-562.2003 · Cited by 209
Antibiotic treatment enhances the genome-wide mutation rate of target cells
Long, H., Miller, S. F., Strauss, C., Zhao, C., Cheng, L., Ye, Z., Griffin, K., Te, R., Lee, H., Chen, C.-C., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1601208113 · Cited by 208
Tsao, Y., Russo, A. A., Nyamuswa, G., SILBER, R. H., & Liu, L. F. (1993) · PubMed · Cited by 206
DNA gyrase on the bacterial chromosome: DNA cleavage induced by oxolinic acid
Snyder, M., & Drlica, K. (1979) · Journal of Molecular Biology · doi:10.1016/0022-2836(79)90077-9 · Cited by 203
Barrett, T. C., Mok, W. W. K., Murawski, A. M., & Brynildsen, M. P. (2019) · Nature Communications · doi:10.1038/s41467-019-09058-4 · Cited by 202
Schmalstieg, A. M., Srivastava, S., Belkaya, S., Deshpande, D., Meek, C., Leff, R., van Oers, N. S. C., & Gumbo, T. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05546-11 · Cited by 195
Vetting, M. W., Hegde, S. S., Fajardo, J. E., Fiser, A., Roderick, S. L., Takiff, H. E., & Blanchard, J. S. (2006) · Biochemistry · doi:10.1021/bi052130w · Cited by 190
Membrane Permeability and Regulation of Drug “Influx and Efflux” in Enterobacterial Pathogens
Davin-Regli, A., Bolla, J.-M., James, C., Lavigne, J.-P., Chevalier, J., Garnotel, E., Molitor, A., & Pages, J.-M. (2008) · Current Drug Targets · doi:10.2174/138945008785747824 · Cited by 188
The export of the DNA replication inhibitor Microcin B17 provides immunity for the host cell.
Garrido, M. C., Herrero, M., Kolter, R., & Moreno, F. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03018.x · Cited by 185
The Structure of Supercoiled Intermediates in DNA Replication
Peter, B. J., Ullsperger, C., Hiasa, H., Marians, K. J., & Cozzarelli, N. R. (1998) · Cell · doi:10.1016/s0092-8674(00)81740-7 · Cited by 184
Pribis, J. P., García-Villada, L., Zhai, Y., Lewin-Epstein, O., Wang, A. Z., Liu, J., Xia, J., Mei, Q., Fitzgerald, D. M., Bos, J., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.02.037 · Cited by 183
Fluoroquinolone-Gyrase-DNA Complexes
Mustaev, A., Malik, M., Zhao, X., Kurepina, N., Luan, G., Oppegard, L. M., Hiasa, H., Marks, K. R., Kerns, R. J., Berger, J. M., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.529164 · Cited by 172
Aldred, K. J., McPherson, S. A., Turnbough, C. L., Kerns, R. J., & Osheroff, N. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt124 · Cited by 171
Efflux pump activity potentiates the evolution of antibiotic resistance across S. aureus isolates
Papkou, A., Hedge, J., Kapel, N., Young, B., & MacLean, R. C. (2020) · Nature Communications · doi:10.1038/s41467-020-17735-y · Cited by 170
Thi, T. D., Lopez, E., Rodriguez-Rojas, A., Rodriguez-Beltran, J., Couce, A., Guelfo, J. R., Castaneda-Garcia, A., & Blazquez, J. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq496 · Cited by 167
López‐Camacho, E., Elez, M., Matić, I., & Blázquez, J. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05642.x · Cited by 166
Understanding and Sensitizing Density-Dependent Persistence to Quinolone Antibiotics
Gutierrez, A., Jain, S., Bhargava, P., Hamblin, M., Lobritz, M. A., & Collins, J. J. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.11.012 · Cited by 165
Oethinger, M., Podglajen, I., Kern, W. V., & Levy, S. B. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.8.2089 · Cited by 164
Arabidopsis thaliana DNA gyrase is targeted to chloroplasts and mitochondria
Wall, M. K., Mitchenall, L. A., & Maxwell, A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400836101 · Cited by 161
Self-citationPathways for repair of topoisomerase I covalent complexes in Saccharomyces cerevisiae
Pouliot, J. J., Robertson, C. A., & Nash, H. A. (2001) · Genes to Cells · doi:10.1046/j.1365-2443.2001.00452.x · Cited by 152
Quinolone Resistance: Much More than Predicted
Hernández, A., Sánchez, M. B., & Martínez, J. L. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00022 · Cited by 142
Ysern, P., Clerch, B., Castańo, M., Gibert, I., Barbé, J., & Llagostera, M. (1990) · Mutagenesis · doi:10.1093/mutage/5.1.63 · Cited by 140
Non-Target Gene Mutations in the Development of Fluoroquinolone Resistance in Escherichia coli
Kern, W. V., Oethinger, M. D., Jellen-Ritter, A., & Levy, S. B. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.814-820.2000 · Cited by 140
Antibacterial action of quinolones: From target to network
Cheng, G., Hao, H., Dai, M., Liu, Z., & Yuan, Z. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.01.057 · Cited by 139
A topological view of the replicon
Schvartzman, J. B., & Stasiak, A. (2004) · EMBO Reports · doi:10.1038/sj.embor.7400101 · Cited by 136
Willmott, C., Critchlow, S. E., Eperon, I. C., & Maxwell, A. (1994) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.1586 · Cited by 136
Self-citationIdentification for mar mutants among quinolone-resistant clinical isolates of Escherichia coli
Maneewannakul, K., & Levy, S. B. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.7.1695 · Cited by 135
Characterization of fluoroquinolone-resistant mutants of escherichia coli selected in vitro
Heisig, P., & Tschorny, R. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.6.1284 · Cited by 132
Safety of Fluoroquinolones: An Update
Mandell, L., & Tillotson, G. S. (2002) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2002/864789 · Cited by 128
Efflux pump inhibitors (EPIs) as new antimicrobial agents against Pseudomonas aeruginosa
Askoura, M., Mattawa, W., Abujamel, T. S., & Taher, I. (2011) · Libyan Journal of Medicine · doi:10.3402/ljm.v6i0.5870 · Cited by 127
Antibiotic-Induced Genetic Variation: How It Arises and How It Can Be Prevented
Blázquez, J., Rodríguez-Beltrán, J., & Matić, I. (2018) · Annual Review of Microbiology · doi:10.1146/annurev-micro-090817-062139 · Cited by 125
Takei, M., Fukuda, H., Kishii, R., & Hosaka, M. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3544-3547.2001 · Cited by 123
Durkin, M. J., Keller, M. R., Butler, A. M., Kwon, J. H., Dubberke, E. R., Miller, A. C., Polgreen, P. M., & Olsen, M. A. A. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy198 · Cited by 121
Montero, C. I., Mateu, G., Rodríguez, R., & Takiff, H. E. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3387-3392.2001 · Cited by 117
Mo, C. Y., Manning, S. A., Roggiani, M., Culyba, M. J., Samuels, A. N., Sniegowski, P., Goulian, M., & Kohli, R. M. (2016) · mSphere · doi:10.1128/msphere.00163-16 · Cited by 112
Delafloxacin: Place in Therapy and Review of Microbiologic, Clinical and Pharmacologic Properties
Jorgensen, S. C. J., Mercuro, N. J., Davis, S. L., & Rybak, M. J. (2018) · Infectious Diseases and Therapy · doi:10.1007/s40121-018-0198-x · Cited by 109
Effect of subinhibitory concentrations of ciprofloxacin on Mycobacterium fortuitum mutation rates
Gillespie, S. H., Basu, S., Dickens, A. L., et al. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki191 · Cited by 108
Excision repair of topoisomerase DNA-protein crosslinks (TOP-DPC)
Sun, Y., Saha, S. T., Wang, W., Saha, L. K., Huang, S.-Y. N., & Pommier, Y. G. (2020) · DNA repair · doi:10.1016/j.dnarep.2020.102837 · Cited by 105
Contribution of reactive oxygen species to thymineless death in Escherichia coli
Hong, Y., Li, L., Luan, G., Drlica, K., & Zhao, X. (2017) · Nature Microbiology · doi:10.1038/s41564-017-0037-y · Cited by 104
Induction and Inhibition of Ciprofloxacin Resistance-Conferring Mutations in Hypermutator Bacteria
Cirz, R. T., & Romesberg, F. E. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.1.220-225.2006 · Cited by 103
López‐Camacho, E., & Blázquez, J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00358-09 · Cited by 103
Nucleolytic processing of a protein-bound DNA end by the E. coli SbcCD (MR) complex.
Connelly, J. C., de Leau, E., & Leach, D. (2003) · DNA Repair · doi:10.1016/s1568-7864(03)00063-6 · Cited by 101
Theodore, A. D., Lewis, K., & Vulić, M. (2013) · Genetics · doi:10.1534/genetics.113.152306 · Cited by 101
Clinical Importance and Epidemiology of Quinolone Resistance
Kim, E. S., & Hooper, D. C. (2014) · Infection and Chemotherapy · doi:10.3947/ic.2014.46.4.226 · Cited by 101
Goneau, L. W., Yeoh, N., MacDonald, K. W., Cadieux, P. A., Burton, J. P., RAZVI, H. A., & Reid, G. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02552-13 · Cited by 99
Fluoroquinolone induction of phage-mediated gene transfer in multidrug-resistant Salmonella
Bearson, B. L., & Brunelle, B. W. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.04.008 · Cited by 95
Trovafloxacin-Induced Acute Hepatitis
Lucena, M. I., Andrade, R. J., Rodrigo, L., Salmerón, J., Alvarez, A., Lopez-Garrido, M. J., Camargo, R., & Alcántara, R. (2000) · Clinical Infectious Diseases · doi:10.1086/313680 · Cited by 95
In front of and behind the replication fork: bacterial type IIA topoisomerases
Sissi, C., & Palumbo, M. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0299-5 · Cited by 93
Xiong, X., Bromley, E. H. C., Oelschlaeger, P., Woolfson, D. N., & SPENCER, J. M. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1296 · Cited by 92
Pereira, R. V. V., Siler, J. D., Ng, J. C., Davis, M. A., Grohn, Y. T., & Warnick, L. D. (2014) · Journal of Dairy Science · doi:10.3168/jds.2014-8521 · Cited by 90
Worldwide clinical data on efficacy and safety of ciprofloxacin
Schacht, P., Chyský, V., Gruenwaldt, G., Hullmann, R., Weuta, H., Arcieri, G., Griffith, E., O'Brien, B., Branolte, J. H., Bruck, H., et al. (1988) · Infection · doi:10.1007/bf01650504 · Cited by 88
4-Quinolones and the SOS response
Lewin, C. S., Howard, B. M. A., Ratcliff, N. T., & Smith, J. T. (1989) · Journal of Medical Microbiology · doi:10.1099/00222615-29-2-139 · Cited by 87
Norfloxacin: A New Targeted Fluoroquinolone Antimicrobial Agent
Wolfson, J. S., & HOOPER, D. C. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-2-238 · Cited by 83
Wentzell, L. M., & Maxwell, A. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4266 · Cited by 83
Self-citationThiophene antibacterials that allosterically stabilize DNA-cleavage complexes with DNA gyrase
Chan, P. F., Germe, T., Bax, B. D., Huang, J., Thalji, R. K., Bacqué, E., Checchia, A., Chen, D., Cui, H., Ding, X., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700721114 · Cited by 83
Self-citationBerger, J. M. (1998) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(98)80006-7 · Cited by 82
The Microbial Toxin Microcin B17: Prospects for the Development of New Antibacterial Agents
Collin, F., & Maxwell, A. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.05.050 · Cited by 82
Self-citationPohlhaus, J. R., & Kreuzer, K. N. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04638.x · Cited by 80
Goldman, J. D., White, D. G., & Levy, S. B. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.5.1266 · Cited by 80
Piddock, L. J. V., Walters, R. N., & Diver, J. M. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.12.2331 · Cited by 78
Ching, C., & Zaman, M. H. (2020) · Scientific Reports · doi:10.1038/s41598-020-65602-z · Cited by 78
The role of moxifloxacin in tuberculosis therapy
Gillespie, S. H. (2016) · European Respiratory Review · doi:10.1183/16000617.0085-2015 · Cited by 77
McDaniel, L. S., Rogers, L., & Hill, W. E. (1978) · Journal of Bacteriology · doi:10.1128/jb.134.3.1195-1198.1978 · Cited by 76
Quinolone Resistance Due to Reduced Target Enzyme Expression
İnce, D., & Hooper, D. C. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.23.6883-6892.2003 · Cited by 74
Delafloxacin: design, development and potential place in therapy
Candel, F. J., & Peñuelas, M. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s106071 · Cited by 73
Quinolone Resistance Reversion by Targeting the SOS Response
Recacha, E., Machuca, J., de Alba, P. D., Ramos-Guelfo, M. S., Docobo-Pérez, F., Rodríguez-Beltrán, J., Blázquez, J., Pascual, Á., & Rodríguez-Martínez, J. M. (2017) · mBio · doi:10.1128/mbio.00971-17 · Cited by 73
Barceló, C. T., Kojadinovic, M., Moxon, R. E., & MacLean, R. C. (2015) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2015.0885 · Cited by 70
Gualerzi, C. O., Brandi, L., Fabbretti, A., & Pon, C. L. (2013) · Wiley eBooks · doi:10.1002/9783527659685 · Cited by 65
Mycobacterium tuberculosis DNA repair in response to subinhibitory concentrations of ciprofloxacin
O’Sullivan, D. M., Hinds, J., Butcher, P. D., Gillespie, S. H., & McHugh, T. D. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn387 · Cited by 65
The Rise of Fluoroquinolone-Resistant Escherichia coli in the Community: Scarier Than We Thought
Spellberg, B. J., & Doi, Y. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv279 · Cited by 58
Rodríguez-Rosado, A. I., Morante, E. Y. V., Rodríguez-Rojas, A., Costas, C., Galhardo, R. S., Rodríguez-Beltrán, J., & Blázquez, J. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz210 · Cited by 57
Direct Evidence for the Formation of Precatenanes during DNA Replication
Cebrián, J., Castán, A., Martínez, V., Kadomatsu-Hermosa, M. J., Parra, C., Fernández-Nestosa, M. J., Schaerer, C. E., Hernández, P., Krimer, D. B., & Schvartzman, J. B. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.642272 · Cited by 51
Segev, S., Yaniv, I., Haverstock, D. C., & Reinhart, H. H. (1999) · Clinical Infectious Diseases · doi:10.1086/515132 · Cited by 48
Storvik, K. A. M., & Foster, P. L. (2010) · Journal of Bacteriology · doi:10.1128/jb.00358-10 · Cited by 46
Analysis of Pleiotropic Transcriptional Profiles: A Case Study of DNA Gyrase Inhibition
Jeong, K. S., Xie, Y., Hiasa, H., & Khodursky, A. B. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020152 · Cited by 45
Bacterial Resistance to Antibiotics – From Molecules to Man
(2019) · Wiley eBooks · doi:10.1002/9781119593522 · Cited by 41
Elimination of plasmids from Enterobacteriaceae by 4-quinolone derivatives
Michel-Briand, Y., Uccelli, V., Laporte, J.-M., & Plésiat, P. (1986) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/18.6.667 · Cited by 38
Mutational Consequences of Ciprofloxacin in Escherichia coli
Song, L. Y., Goff, M., Davidian, C., Mao, Z., London, M., Lam, K., Yung, M., & Miller, J. H. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01415-16 · Cited by 36
Biphasic kinetics of bacterial killing by quinolones
Carret, G., Flandrois, J., & Lobry, J. R. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/27.3.319 · Cited by 35
Tattevin, P., Basuino, L., & Chambers, H. F. “. (2009) · Research in Microbiology · doi:10.1016/j.resmic.2009.03.003 · Cited by 33
Almalki, Z. S., Yue, X., Xia, Y., Wigle, P. R., & Guo, J. J. (2016) · PharmacoEconomics - Open · doi:10.1007/s41669-016-0007-y · Cited by 32
Ahuja, S. D., Ashkin, D., Avendano, M., Banerjee, R., Bauer, M., Bayona, J. N., Becerra, M. C., Benedetti, A., Burgos, M. V., Centis, R., et al. (2012) · PLoS Medicine · doi:10.1371/annotation/230240bc-bcf3-46b2-9b21-2e6e584f7333 · Cited by 30
Rational use of the fluoroquinolones
Richards, G., Brink, A. J., & Feldman, C. H. (2019) · South African Medical Journal · doi:10.7196/samj.2019.v109i6.14002 · Cited by 27
Klitgaard, R. N., Jana, B., Guardabassi, L., Nielsen, K. L., & Løbner‐Olesen, A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01438 · Cited by 24
Resistance and Virulence Mechanisms of Escherichia coli Selected by Enrofloxacin in Chicken
Li, J., Hao, H., Dai, M., Zhang, H., Ning, J., Cheng, G., Shabbir, M. A. B., Sajid, A., & Yuan, Z. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01824-18 · Cited by 22
Chuppava, B., Keller, B., El‐Wahab, A. A., Meißner, J., Kietzmann, M., & Visscher, C. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15091993 · Cited by 19
Henderson, M. L., & Kreuzer, K. N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128092 · Cited by 16
The RuvAB Branch Migration Complex Can Displace Topoisomerase IV·Quinolone·DNA Ternary Complexes
Shea, M. E., & Hiasa, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304217200 · Cited by 13
Recent Developments in Inhibitors of Bacterial Type IIA Topoisomerases
Chan, P. F., Huang, J., Bax, B. D., & Gwynn, M. N. (2013) · Antibiotics · doi:10.1002/9783527659685.ch11 · Cited by 13
Ching, C., Orubu, E. S. F., Wirtz, V. J., & Zaman, M. H. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-030747 · Cited by 13
Molecular and Genetic Characteristics of Cell Death in Prokaryotes
Andryukov, B. G., Somova, L., & Тимченко, Н. Ф. (2018) · Molecular Genetics Microbiology and Virology · doi:10.3103/s0891416818020039 · Cited by 5
Cited by
Molecular mechanisms of antibiotic resistance revisited
Darby, E. M., Trampari, E., Siasat, P., Gaya, M. S., Alav, I., Webber, M. A., & Blair, J. M. A. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00820-y · Cited by 1,398
Shariati, A., Arshadi, M., Khosrojerdi, M. A., Abedinzadeh, M., Ganjalishahi, M., Maleki, A., Heidary, M., & Khoshnood, S. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.1025633 · Cited by 337
Antibiotics and Bacterial Resistance—A Short Story of an Endless Arms Race
Baran, A., Kwiatkowska, A., & Potocki, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065777 · Cited by 300
Hou, L., Ji, Y., Zhao, J., & Zhao, L. (2022) · Microchemical Journal · doi:10.1016/j.microc.2022.107664 · Cited by 27
Metadata
- Authors
- Bush, N. G., Diez-Santos, I., Abbott, L. R., & Maxwell, A.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2020-12-01
- Volume
- 25
- Issue
- 23
- Pages
- 5662
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W3107825098
- Cited by
- 413
- References
- 173
- FWCI
- 10.99
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.